Empagliflozin Tablets 10mg (Pingxinda) – For Research Use Only

Empagliflozin Tablets 10mg (Pingxinda) – For Research Use Only

$1.20

Empagliflozin Tablets 10mg (Pingxinda) are used in laboratory research focused on SGLT2 inhibition and glucose excretion. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. For research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Empagliflozin Tablets 10mg, marketed under the name Pingxinda, are designed for experimental use in laboratory settings to support studies involving glucose regulation, SGLT2 inhibition, and type 2 diabetes mellitus (T2DM). These tablets inhibit sodium-glucose co-transporter 2 (SGLT2) in renal proximal tubules, resulting in reduced reabsorption of glucose and increased urinary glucose excretion in research models.

Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., this product is approved under H20234642 and adheres to GMP production standards.

?? For laboratory research use only. Not for human use.


Product Parameters

Attribute Details
Product Name Empagliflozin Tablets
Brand Name Pingxinda (???)
CAS Number 864070-44-0
Molecular Formula C23H27ClO7
Strength 10mg
Dosage Form Tablets
Specification 10 tablets per box
Approval Number H20234642
Product Code 86905847001015
Manufacturer Qilu Pharmaceutical (Hainan) Co., Ltd.
Package Unit Box
Intended Use Research only
Barcode 6949384101351

Mechanism & Research Applications

Empagliflozin is a selective SGLT2 inhibitor. It blocks the reabsorption of glucose in the kidney, leading to increased urinary glucose excretion. In preclinical research, this helps simulate conditions similar to those found in patients with type 2 diabetes.

Research applications include:

  • Investigating glucose metabolism pathways

  • Studying renal sodium-glucose co-transport inhibition

  • Modeling T2DM therapies in vitro or in vivo

  • Testing combinatorial therapies with metformin or DPP-4 inhibitors


Observed Effects in Research

  • Reduced fasting and postprandial blood glucose in test models

  • Increased urinary glucose output

  • Weight loss and improved insulin sensitivity in rodents

  • Reduced systolic blood pressure markers

  • Delayed progression of diabetic kidney disease in long-term studies


Safety & Handling

  • Research Grade Only – Not for clinical, diagnostic, or human use

  • Storage – Store below 25°C in a dry, light-protected environment

  • Handling – Use PPE: gloves, lab coat, eye protection

  • Shelf Life – Refer to packaging or Certificate of Analysis

  • Disposal – Follow institutional guidelines for chemical disposal


Research Use Disclaimer

This product is intended strictly for laboratory research use only. It is not for human or veterinary use, not a drug, and should only be handled by trained professionals.

其他信息

重量 1 公斤
尺寸 26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Empagliflozin Tablets 10mg (Pingxinda) – For Research Use Only” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: What are Empagliflozin Tablets used for in research?

They are used to investigate the role of SGLT2 inhibitors in glucose reabsorption and their potential benefits in diabetes and renal-related studies.

Q2: Is Pingxinda safe for human consumption?

No. Pingxinda (Empagliflozin 10mg) is strictly for research use only and should not be used in humans or animals.

Q3: Can I order this product in bulk?

Yes, we support both wholesale and retail distribution. Please contact us for pricing and documentation.

Q4: Does this product come with a COA and SDS?

Yes. A Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request or included with each shipment.

Q5: Why is Empagliflozin a preferred compound in type 2 diabetes research?

Due to its role as a potent SGLT2 inhibitor, Empagliflozin Tablets 10mg are frequently used in T2DM model studies to evaluate glycemic control mechanisms and renal glucose handling.


EMI Options

Select at least 2 products
to compare